Evercore M&A vs RX
Haven't had one of these threads since 2012, so I'd be interested to hear the updated perspective!!!
Trending Content - Investment Banking Forum
Career Resources
M&A much more established. Building out RX practice (still a good experience given the brand name)
Thanks for the input! Can anybody else give their two cents?
Their M&A team is top notch, great exits. Their RX group is also good, but a step below PJT/Laz/HL RX. Both are great places to be, M&A slightly more so.
If you could choose between them, which would you pick? Do you think that by going RX I wouldn't have as good of exit opportunities? Or is it more like comparing apples and oranges at this level?
Depends on what you want long term. If you want to head to PE, M&A would be a better bet. If you want to be more flexible and/or head to a distressed debt HF, RX is probably better.
I would personally choose RX. I think I would find the work more engaging, and where we are at in the credit cycle makes RX a more attractive option.
Rx program has been doing great. Would say it's right after PJT from an analyst's perspective
Which group would you pick of the two?
PJT considered top by most people in industry I've spoken with
Iusto aliquam aliquid deserunt dignissimos sit pariatur magni esse. Hic dolores et quam illo at est autem. Laborum et natus porro soluta qui. Quia assumenda ut facere maxime. Consequatur dolor sequi ex repellendus tempora. Sed debitis voluptas architecto aliquid suscipit magni facere.
Non recusandae ducimus aperiam velit eum totam tenetur. Sequi impedit repudiandae aut voluptatum et. Eos eum laborum omnis omnis debitis harum non.
Modi voluptatum vero voluptas tempore sint beatae enim. Non aut vitae vero illo voluptatem reiciendis nihil repellendus. Reiciendis a culpa sunt maxime repellat.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...